AEON Biopharma reported net income of -$1.16M for the quarter ended Jun 2026. This income statement covers 22 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating items | ||||||||||||||||||||||
| Research & DevelopmentR&D | 7.48M | 9.53M | 9.21M | 9.03M | 6.39M | 5.73M | 4.44M | 0.97M | 3.04M | 0.82M | 1.06M | 0.60M | 1.61M | 2.94M | ||||||||
| Selling, General & AdministrativeSG&A | 2.44M | 5.50M | 3.84M | 4.95M | 5.26M | 4.65M | 3.32M | 3.04M | 2.63M | 3.12M | 3.26M | 1.93M | 3.89M | 2.99M | ||||||||
| Other Operating ExpensesOther Opex | 0.40M | 0.45M | 0.89M | 0.39M | 0.43M | 272.06M | 63.77M | -161.23M | -3.35M | -3.49M | 0.02M | -0.04M | 0.01M | -0.01M | ||||||||
| Operating ExpensesOpex | 0.40M | 0.45M | 0.89M | 0.39M | 0.43M | 9.91M | 15.03M | 13.05M | 13.97M | 283.71M | 74.15M | -153.47M | 4.02M | 2.32M | 0.46M | 4.34M | 2.49M | 5.51M | 5.92M | |||
| Operating IncomeOp. Inc | -0.40M | -0.45M | -0.89M | -0.39M | -0.43M | -9.91M | -15.03M | -13.05M | -13.97M | -283.71M | -74.15M | 153.47M | -4.02M | -2.32M | -0.46M | -4.34M | -2.49M | -5.51M | -5.92M | |||
| EBIT | -0.40M | -0.45M | -0.89M | -0.39M | -0.43M | -9.91M | -15.03M | -13.05M | -13.97M | -283.71M | -74.15M | 153.47M | -4.02M | -2.32M | -0.46M | -4.34M | -2.49M | -5.51M | -5.92M | |||
| Non-operating items | ||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.03M | 0.02M | 0.02M | 0.13M | 0.14M | 1.15M | 2.29M | 1.70M | 0.20M | |||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.14M | 0.15M | 0.06M | 0.04M | 0.19M | 0.04M | 0.03M | 0.02M | 0.00M | 0.10M | 0.09M | 0.07M | 0.03M | 0.04M | ||||||||
| Non Operating IncomeNon Op. Inc. | -3.63M | 6.11M | 1.13M | 3.16M | 2.31M | -0.53M | -19.53M | -4.59M | -1.41M | -14.00M | -43.87M | 10.64M | -2.15M | 4.40M | 9.56M | -2.30M | -2.04M | -31.63M | 4.76M | |||
| Net income details | ||||||||||||||||||||||
| EBT | -4.03M | 5.66M | 0.25M | 2.77M | 1.88M | -10.44M | -34.56M | -17.64M | -15.38M | -297.71M | -118.02M | 164.11M | -6.17M | 2.08M | 9.10M | -6.64M | -4.54M | -37.14M | -1.16M | |||
| Tax ProvisionsTaxes | 0.02M | 0.40M | 0.09M | -0.50M | ||||||||||||||||||
| Profit After TaxPAT | -4.03M | 5.66M | 0.25M | 2.77M | 1.87M | 1.64M | 0.09M | -0.39M | -3.94M | -297.71M | -118.02M | 164.11M | -6.17M | 2.08M | 9.10M | -6.64M | -4.54M | -37.14M | -1.16M | |||
| Income from Continuing OperationsIncome (Continuing) | -4.03M | 5.66M | 0.25M | 2.77M | 1.87M | -10.44M | -34.56M | -18.04M | -15.47M | -297.71M | -118.02M | 164.11M | -6.17M | 2.58M | 9.10M | -6.64M | -4.54M | -37.14M | -1.16M | |||
| Consolidated Net IncomeConsol Net Inc. | -4.03M | 5.66M | 0.25M | 2.77M | 1.87M | -10.44M | -34.56M | -18.04M | -15.47M | -297.71M | -118.02M | 164.11M | -6.17M | 2.58M | 9.10M | -6.64M | -4.54M | -37.14M | -1.16M | |||
| Income towards Parent CompanyParent Net Inc | -4.03M | 5.66M | 0.25M | 2.77M | 1.87M | -10.44M | -34.56M | -18.04M | -15.47M | -297.71M | -118.02M | 164.11M | -6.17M | 2.58M | 9.10M | -6.64M | -4.54M | -37.14M | -1.16M | |||
| Net Income towards Common StockholdersNet Income | -3.22M | 4.53M | 0.29M | 2.22M | 1.49M | 1.31M | 0.07M | -0.25M | -3.06M | -297.71M | -118.02M | 164.11M | -6.17M | 2.58M | 9.10M | -6.64M | -4.54M | -37.14M | -1.16M | |||
| Additional items | ||||||||||||||||||||||
| EPS (Basic) | -0.47 | 0.13 | 0.01 | 0.06 | 0.04 | 0.04 | 0.00 | -0.02 | -0.44 | -8.01 | -3.17 | 4.22 | -0.16 | 4.77 | 2.28 | -0.60 | -0.39 | -3.74 | -0.02 | |||
| EPS (Diluted) | -0.12 | 0.16 | 0.01 | 0.06 | 0.05 | 0.05 | 0.00 | -0.01 | -0.34 | -8.01 | -3.17 | 4.22 | -0.16 | 4.48 | 2.28 | -0.60 | -0.39 | -3.74 | -0.02 | |||
| Shares Outstanding | 6.90M | 34.50M | 55.81M | 34.50M | 34.50M | 34.50M | 27.60M | 13.09M | 6.90M | 37.16M | 37.16M | 37.27M | 38.84M | 39.52M | 0.54M | 3.98M | 11.09M | 11.63M | 9.92M | 50.53M | ||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 27.60M | 27.60M | 55.81M | 34.50M | 27.60M | 27.60M | 34.50M | 19.99M | 8.90M | 37.16M | 37.16M | 37.27M | 38.84M | 39.52M | 0.58M | 3.98M | 11.09M | 11.63M | 9.92M | 50.53M | ||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 46.52M | 34.50M | 55.81M | 34.50M | 34.50M | 55.76M | 34.50M | 13.09M | 8.90M | 37.16M | 37.16M | 38.12M | 39.12M | 39.59M | 0.54M | 3.98M | 11.54M | 11.64M | 9.92M | 50.53M | ||
| EBITDA | -0.40M | -0.45M | -0.89M | -0.39M | -0.43M | -9.91M | -15.03M | -13.05M | -13.97M | -283.71M | -74.15M | 153.47M | -4.02M | -2.32M | -0.46M | -4.34M | -2.49M | -5.51M | -5.92M | |||
| Tax Rate | 0.90% | -2.29% | -0.60% | -23.84% |